Skip to main content
HeXun Biosciences Co., Ltd. (TPEX: 6986)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
70.70
+0.10 (0.14%)
Nov 15, 2024, 1:34 PM CST

HeXun Biosciences Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2023 FY 2022 FY 2021
Period Ending
 Nov '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3,3902,981--
Enterprise Value
3,1462,763--
Last Close Price
73.7064.80--
PE Ratio
27.3387.66--
PS Ratio
14.3522.83--
PB Ratio
6.166.30--
P/TBV Ratio
6.586.79--
P/FCF Ratio
112.02132.95--
P/OCF Ratio
51.2969.18--
EV/Sales Ratio
13.3121.16--
EV/EBITDA Ratio
22.9464.08--
EV/EBIT Ratio
27.06100.94--
EV/FCF Ratio
103.96123.24--
Debt / Equity Ratio
0.060.150.230.35
Debt / EBITDA Ratio
0.251.5613.75-
Debt / FCF Ratio
1.123.247.16-
Asset Turnover
0.420.270.14-
Quick Ratio
12.1111.679.8210.87
Current Ratio
12.6912.0510.5511.94
Return on Equity (ROE)
25.43%8.50%-1.96%-
Return on Assets (ROA)
12.81%3.51%-1.61%-
Return on Capital (ROIC)
13.38%3.67%-1.66%-
Earnings Yield
3.66%1.12%--
FCF Yield
0.89%0.75%--
Buyback Yield / Dilution
-10.22%-20.81%-22.92%-
Total Shareholder Return
-10.22%-20.81%-22.92%-
Source: S&P Capital IQ. Standard template. Financial Sources.